18-MAR-1987 11:21:06.19

LYPHOMED <LMED> TO MARKET ANTIBIOTIC

LyphoMed Inc said the Food and Drug Administration gave it approval to market Vancomycin HCL, an antibiotic used in hospitals to treat life-threatening infections.     It said the product is currently marketed by Eli Lilly and Co <LLY> under the trade name Vancocin. Sales in 1986 were 110 mln dlrs.     LyphoMed said its objective is to get a 15 to 20 pct share of the market.  Reuter &#3;

